The company announces the release and immediate availability of a specific scanner reading protocol dedicated to COVID-19.

Intrasense™ announces its 2019 annual results.

Artificial intelligence will be highlighted on Intrasense™ booth (#6956). The new version of Myrian® platform enabling artificial intelligence to truly be embedded into the daily workflow and clinical routine.

All innovations will be presented at JFR 2019 on the Intrasense ™ booth (# 213A). The new version of Myrian® as well as the XP-Mammo application will be display.

This new version of Myrian® brings many clinical innovations and a new application.

Achieving a positive Net Income within this first 2019 semester validates the strategic choices set by the new governance in 2018, generating profits for the first half of 2019 financial year.

Myrian® XP-Mammo, can now be commercialized on the European market.

Myrian® XP Prostate, the new reference tool for worldwide prostate experts.

Elonav, a brand-new application dedicated to specifical needs of neurosurgeons.

Presentation of 3 innovative products based on Myrian® technology.